ABSTRACT -High-grade mucoepidermoid carcinomas (MECs) have difficulty in cure and 5-year survival rate is quiet low. Therefore, we need new therapeutic agents and molecular targets. Betulinic acid (BA) is one of the materials which is easily found in the world and shows tumor-suppress effects in various tumor types. In addition, many kinds of normal tissues have a resistance to BA treatment. In this study, we investigated the anti-proliferative activity of BA and its molecular targets in MC-3 human MEC cells using western blot analysis and DAPI staining. BA inhibited cell viability and induced apoptosis in MC-3 cells. It affected Specificity protein 1 (Sp1) and its downstream molecule, survivin whereas it did not affect myeloid cell leukemia-1 (Mcl-1). Therefore, we suggest that BA can be a potential anti-cancer drug candidate regulating Sp 1 and survivin to exert apoptotic cell death.
Introduction
Mucoepidermoid carcinoma (MEC) is the most frequently occurring primary malignancy of salivary glands in all age patients, representing 5% of whole salivary gland tumors and 35% of whole malignant tumors [1] [2] [3] . Low-grade MECs rarely recur; after surgery, most patients are fully cured and the 5-year survival rate is 76-95%. Conversely, high-grade MEC is aggressive tumor that may have an invasive form of growth, recur and metastasize, and its 5-year survival rate is only 30-50% 4) . Therefore, it is important to find a new treatment agent and a potential molecular target for therapeutic strategies in MEC.
Natural materials have been used to treat human diseases for thousands of years 5) . Betulinic acid (BA) is a naturally occurring pentacyclic triterpenoid of the lupane class that belongs to the group of terpenes and is found abundantly in bushes and trees, forming the principal extractive (up to 30% of dry weight) of the bark of birch trees [6] [7] [8] . BA inhibits the growth of several tumors but normal tissues were shown to have the resistance to BA treatment in vitro [9] [10] [11] . Therefore, we regarded BA as a good potential anti-cancer drug candidate which has therapeutic effects with less side effects. In previous studies, the anticancer activity of BA was subsequently reported in several types of human malignancies, including head and neck tumors 12) . However, there is no study for MEC with BA. Therefore we performed therapeutic effects of BA in MEC.
Materials and Methods

Reagents
The antibodies for Poly (ADP-ribose) Polymerase (PARP) (Asp175), cleaved caspase-3(Asp). Mcl-1 and survivin were obtained from BD Biosciences (San Jose, CA, USA) and Cell Signaling Technology (Danvers, MA, USA), respectively. Antibodies for Sp1 and actin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Betulinic acid (BA) was purchased by Alexis (San Diego, CA, USA). 4'-6-Diamidino-2-phenylindole (DAPI) was acquired from Sigma-Aldrich Chemical Co. (St.Louis, MO, USA). 
Cell
DAPI staining
Apoptotic cell death was determined morphologically using a fluorescent nuclear dye, DAPI. DAPI staining showed the number of apoptotic cells with chromatin condensation and nuclear fragmentation. MC-3 cells were incubated with DMSO or various concentrations of BA (7.5, 15, and 30 µM) for 24 h, then harvested by trypsinization, and fixed in 70% ethanol overnight at 4 o C. The next day, the cells were stained with DAPI, deposited onto the slides, and finally viewed to detect apoptotic characteristics with a fluorescent microscope.
Western blot analysis MC-3 cells were grown in 60 mm
2 dishes and treated with DMSO or BA. Whole-cell lysates were extracted and quantified using a protein assay kit. Total protein from each sample was mixed with 5 µl loading buffer and heated at > 90 o C for 5 min. Equal amounts of protein were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred onto poly (vinylidene fluoride) (PVDF) membrane (Bio-Rad Laboratories). The membranes were blocked with 5% skim milk in TBST buffer at room temperature for 2 h, washed with TBST, and incubated overnight at 4 o C with primary antibody. Washing was done with TBST, and incubation with horseradish peroxidase (HRP)-conjugated secondary antibody was done at room temperature for 2 h. After washing with TBST, detection was performed with ECL Western blotting reagents (Santa Cruz, CA). For loading control, the membranes were stripped and reprobed with HRP conjugated anti-β-actin.
Statistical Analysis
The data were assessed for statistical significance using a Student's t test. A value of p < 0.05 compared to the vehicle control was considered to be statistically significant.
Results
BA Decreases the Cell Viability of MC-3 Cells
To investigate the growth-inhibitory effect of BA in MEC, MC-3 cells were treated by DMSO or various concentrations of BA. The result showed that the number of cells decreased compared with the vehicle control in a concentrationdependent manner (Fig. 1A and B) . We suggest that BA inhibits MC-3 cell growth.
BA induces apoptosis in MC-3 cell line
To examine whether BA-induced growth inhibition was occurred through apoptosis, we determined the level of PARP and caspase-3 cleavage, both of all present features of cells undergoing apoptosis, by Western blot analysis. After BA treatment for 24 hr, total PARP was decreased and cleaved Caspase-3 was detected in MC-3 cells (Fig. 2) . Thus, these results indicated that BA induced apoptosis in MC-3 cells suggesting that the growth inhibition of MC-3 cells by BA is due to apoptotic cell death. To confirm whether BA induced apoptosis in MC-3 cell line, DAPI staining was performed. The results showed the fragmentation and condensation of nucleus in the cells treated with BA (7.5, 15 and 30 µM) for 24 h compared with the DMSO-treated cells (Fig. 3) . Overall, these findings ( Fig. 2 and 3) suggested that BA could induce apoptosis in MC-3 cells.
BA inhibits anti-apoptotic protein Sp1 and its downstream protein, survivin, in MC-3 cells
In previous studies, Specificity protein 1 (Sp1) might be a potential molecular target for various cancer treatment 13) . We performed whether BA affects Sp1 protein to induce apoptotic cell death in MC-3 cells. As shown in Figure 4 , BA-treated MC-3 cells were exhibited the decrease of Sp1 expression in a concentration-dependent manner. This finding showed that Sp1 may be related with apoptosis by BA in MC-3 cells. Survivin and Myeloid cell leukemia-1 (Mcl-1) are downstream proteins of Sp1 14, 15) . We investigated the effect of BA on survivin and Mcl-1 in MC-3 cells treated with BA for 24 hr. The results showed that BA decreased survivin but not Mcl-1 protein expression (Fig. 4) . We can infer that Sp1 and survivin are related with apoptosis by BA in MC-3 cells.
Discussion
MEC is one of the most common malignant neoplasm of the salivary glands, exhibiting variable growth pattern and morphological diversity 16, 17) . Therefore the finding of a new potent, less toxic anti-cancer agent is important. BA is contained in various plants throughout the plant kingdom and, hence, in the whole world and features potent antitumor activities 18, 19) . Moreover, normal cells that have different origins reported to have resistance to BA than tumor cells 20, 21) . Therefore, we regarded BA as an ideal agent which has therapeutic effects and less toxicity for cancer treatment. Objectives of this study are finding a therapeutic agent candidate, researching its effects in MC-3 cells and finding out molecular targets.
First of all, we examined the cell growth inhibition of BA in MC-3 cells. After treatment of various concentrations of BA in MC-3 cells, we can find the decrease of cell number and cell viability of MC-3 cells in a concentration-dependent manner. Then, we confirmed that the decrease of MC-3 cells by BA is due to apoptosis mechanism with apoptotic marker PARP and cleaved caspase-3. Also we found DNA fragmentation and condensation of MC-3 cells with BA treatment by DAPI staining. These results showed that BA induces apoptosis in MC-3 cells.
Specificity protein 1 (Sp1) is one of the members of transcription factor family that bind GC/GT-rich promoter elements 22) . Sp1 plays critical role in regulating cell differentiation, cell cycle and apoptosis-related genes influencing cell viability and growth 23) . In addition, Sp1 regulates thousands of genes, such as those encoding vascular endothelial growth factor (VEGF), p21CIP1/WAF1, 12(S)-lipoxygenase, phosphatase 2A (PP2A), and Sp1 itself 13) . Moreover, Sp1 levels Fig. 3 . BA induced apoptotic cell death in MC-3 cells. Cells were incubated with DMSO (vehicle control) or BA (7.5, 15 and 30 µM) for 24 h. Then, cells were harvested and prepared for DAPI staining. DNA fragmentation and nuclear condensation were detected by fluorescence microscopy (magnification × 400). DNA fragmentation and nuclear condensation were quantified. *p < 0.05 compared to the DMSO treatment group. and activity are increased in several cancers as compared with normal tissues 24, 25) . Inhibition of Sp1 expression has been shown to down-regulate tumor cell growth as well as tumor initiation in athymic mice 24, [26] [27] [28] . The importance of Sp 1 as a drug target is due not only to its overexpression in several tumor types but also to its relatively low expression in normal human tissues, and this is consistent with studies that reported the decrease of Sp1 expression in increasing age 29, 30) . Therefore, we inferred that Sp1 can be a potential molecular target for MEC treatment. We confirmed BA affects the decrease of Sp1 expression in MC-3 cells. It suggested that BA might inhibit Sp1 expression to occur its apoptotic cell death mechanism in MC-3 cells because BA modulates the expression of Sp1, it is also important to find target molecules related with apoptosis in its downstream signaling pathway.
Survivin, a member of the inhibitor of apoptosis (IAP1) family proteins, and Myeloid cell leukaemia-1 (Mcl-1), a member of B-cell lymphoma-2 (Bcl-2) family proteins, are known as downstream proteins of Sp1 14, 31) . Survivin is highly expressed in various types of cancer, but not in most normal differentiated tissues 32) . It concerns the regulation of apoptosis and the control of cell cycle and mitosis, and may also play critical roles in other pathophysiological processes, including its important role in tumor formation progression, drug resistance, radiation resistance and tumor relapse [33] [34] [35] [36] [37] . Mcl-1 has been found to be a critical survival factor in hematopoietic 38) . Overexpression of Mcl-1 makes cells exposed to a variety of apoptosis-inducing stimuli survive and decrease of Mcl-1 protein level by antisense oligonucleotides allows cells enter into apoptosis [38] [39] [40] . Therefore we investigated the effect of BA on the expression level of survivin and Mcl-1. We found the decrease of survivin expression but there is no significant change in Mcl-1 expression. These results suggest that BA affects Sp1 and survivin expression, but not Mcl-1 expression.
In conclusion, targeting Sp1 protein with BA to induce apoptotic cell death of MEC cells is quite effective through the inhibition of its downstream target, survivin. These indicate a critical role for Sp1 and survivin in the growth and survival of MEC cells and demonstrate that BA may be a potential anticancer drug candidate for clinical treatment of human MEC. 
